|
Anton Berns is a scientist researching molecular genetics and author of the Mouse Cancer Models studies series. == Career == Anton Berns studied biochemistry at the University of Nijmegen and received his Masters degree in 1969 (cum laude) and his PhD in 1972 (supervisor Prof. H. Bloemendal) from that same University (cum laude). He did his postdoctoral training in the group of Rudolf Jaenisch at the Salk Institute in La Jolla, CA., where he studied the role of retroviruses in causing lymphomas in mice. In 1976 he returned to the University of Nijmegen where he became junior staff member. His group explored proviral insertional mutagenesis as a means to identify new oncogenes. In 1985 he was appointed as staff scientist at the Netherlands Cancer Institute and in 1986 he became head of the Division of Molecular Genetics of the Institute. Here his group did pioneering work to generate and utilize genetically modified mice as a tool to search for new cancer genes. In 1999, he was appointed as Director of Research and Chairman of the Board of Directors of the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital from which he retired at the end of 2011. He continued his research as a group leader in the Division of Molecular Genetics of the NKI.〔(Molecular Genetics: Anton Berns )〕 On June 3, 2013, Anton Berns was approved by the Skolkovo Institute of Science and Technology Board of Trustees as the director for the Centers for Research, Education and Innovation (CREI) that are established to promote partnerships between Russian and non-Russian researchers.〔(Anton Berns: Research is International. (07.26.2013) )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Anton Berns」の詳細全文を読む スポンサード リンク
|